Exercise, cancer, and the cardiovascular system: clinical effects and mechanistic insights

1.

(2024) DiGA ProHerz. In:ProCarement. https://procarement.com/patientinnen/diga/ [accessed 14.01.2024].

2.

Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, Fung K, Anderson GM (2019) The risk of heart failure and other cardiovascular hospitalizations after early stage breast cancer: a matched cohort study. J Natl Cancer Inst 111:854–862. https://doi.org/10.1093/jnci/djy218CrossRefPubMedPubMedCentral

3.

Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, Greenbaum N, Mauch P, Lipshultz SE (2004) Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 22:3139–3148. https://doi.org/10.1200/jco.2004.09.109CrossRefPubMed

4.

Adams SC, DeLorey DS, Davenport MH, Fairey AS, North S, Courneya KS (2018) Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors. Br J Cancer 118:1313–1321. https://doi.org/10.1038/s41416-018-0044-7CrossRefPubMedPubMedCentral

5.

Adams SC, DeLorey DS, Davenport MH, Stickland MK, Fairey AS, North S, Szczotka A, Courneya KS (2017) Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial. Cancer 123:4057–4065. https://doi.org/10.1002/cncr.30859CrossRefPubMed

6.

Adams V, Reich B, Uhlemann M, Niebauer J (2017) Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. Am J Physiol Heart Circ Physiol 313:H72-h88. https://doi.org/10.1152/ajpheart.00470.2016CrossRefPubMed

7.

Agostini D, Natalucci V, Baldelli G, De Santi M, Donati Zeppa S, Vallorani L, Annibalini G, Lucertini F, Federici A, Izzo R, Stocchi V, Barbieri E (2018) New insights into the role of exercise in inhibiting mTOR signaling in triple-negative breast cancer. Oxid Med Cell Longev 2018:5896786. https://doi.org/10.1155/2018/5896786CrossRefPubMedPubMedCentral

8.

Allen SK, Brown V, White D, King D, Hunt J, Wainwright J, Emery A, Hodge E, Kehinde A, Prabhu P, Rockall TA, Preston SR, Sultan J (2022) Multimodal prehabilitation during neoadjuvant therapy prior to esophagogastric cancer resection: effect on cardiopulmonary exercise test performance, muscle mass and quality of Life-A pilot randomized clinical trial. Ann Surg Oncol 29:1839–1850. https://doi.org/10.1245/s10434-021-11002-0CrossRefPubMed

9.

Alvarez Villela M, Chinnadurai T, Salkey K, Furlani A, Yanamandala M, Vukelic S, Sims DB, Shin JJ, Saeed O, Jorde UP, Patel SR (2021) Feasibility of high-intensity interval training in patients with left ventricular assist devices: a pilot study. ESC Heart Fail 8:498–507. https://doi.org/10.1002/ehf2.13106CrossRefPubMed

10.

Ameri P, Canepa M, Anker MS, Belenkov Y, Bergler-Klein J, Cohen-Solal A, Farmakis D, López-Fernández T, Lainscak M, Pudil R, Ruschitska F, Seferovic P, Filippatos G, Coats A, Suter T, Von Haehling S, Ciardiello F, de Boer RA, Lyon AR, Tocchetti CG (2018) Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge. Eur J Heart Fail 20:879–887. https://doi.org/10.1002/ejhf.1165CrossRefPubMed

11.

Anker MS, Lena A, Roeland EJ, Porthun J, Schmitz S, Hadzibegovic S, Sikorski P, Wilkenshoff U, Fröhlich AK, Ramer LV, Rose M, Eucker J, Rassaf T, Totzeck M, Lehmann LH, von Haehling S, Coats AJS, Friede T, Butler J, Anker SD, Riess H, Landmesser U, Bullinger L, Keller U, Ahn J (2023) Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer. J Cachexia Sarcopenia Muscle 14:1670–1681. https://doi.org/10.1002/jcsm.13247CrossRefPubMedPubMedCentral

12.

Arends J, Muscaritoli M, Anker S, Audisio R, Barazzoni R, Bosnjak S, Bossi P, Bowman J, Gijssels S, Krznarić Ž, Strasser F, Aapro M (2023) Overcoming barriers to timely recognition and treatment of cancer cachexia: sharing progress in cancer care task force position paper and call to action. Crit Rev Oncol Hematol 185:103965. https://doi.org/10.1016/j.critrevonc.2023.103965CrossRefPubMed

13.

Attia ZI, Harmon DM, Behr ER, Friedman PA (2021) Application of artificial intelligence to the electrocardiogram. Eur Heart J 42:4717–4730. https://doi.org/10.1093/eurheartj/ehab649CrossRefPubMed

14.

Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K (1996) Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 28:1567–1572. https://doi.org/10.1016/s0735-1097(96)00412-3CrossRefPubMed

15.

Barroso LC, Muro EC, Herrera ND, Ochoa GF, Hueros JI, Buitrago F (2010) Performance of the Framingham and SCORE cardiovascular risk prediction functions in a non-diabetic population of a Spanish health care centre: a validation study. Scand J Prim Health Care 28:242–248. https://doi.org/10.3109/02813432.2010.518407CrossRefPubMedPubMedCentral

16.

Bauer J, Morley JE, Schols A, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD (2019) Sarcopenia: a time for action. an SCWD position paper. J Cachexia Sarcopenia Muscle 10:956–961. https://doi.org/10.1002/jcsm.12483CrossRefPubMedPubMedCentral

17.

Beaudry RI, Haykowsky MJ, MacNamara JP, Tucker WJ, Rao R, Haley B, Sarma S (2022) Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors. Cardiooncology 8:8. https://doi.org/10.1186/s40959-022-00134-1CrossRefPubMedPubMedCentral

18.

Beaudry RI, Howden EJ, Foulkes S, Bigaran A, Claus P, Haykowsky MJ, Gerche A (2019) Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy. Physiol Rep 7:e13971. https://doi.org/10.14814/phy2.13971CrossRefPubMedPubMedCentral

19.

Binder RK, Wonisch M, Corra U, Cohen-Solal A, Vanhees L, Saner H, Schmid JP (2008) Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing. Eur J Cardiovasc Prev Rehabil 15:726–734. https://doi.org/10.1097/HJR.0b013e328304fed4CrossRefPubMed

20.

Blanchard CM, Courneya KS, Stein K (2008) Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol 26:2198–2204. https://doi.org/10.1200/jco.2007.14.6217CrossRefPubMed

21.

Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377–381CrossRefPubMed

22.

Brown JC, Troxel AB, Ky B, Damjanov N, Zemel BS, Rickels MR, Rhim AD, Rustgi AK, Courneya KS, Schmitz KH (2018) Dose-response effects of aerobic exercise among colon cancer survivors: a randomized phase II trial. Clin Colorectal Cancer 17:32–40. https://doi.org/10.1016/j.clcc.2017.06.001CrossRefPubMed

23.

Bryant AL, Deal AM, Battaglini CL, Phillips B, Pergolotti M, Coffman E, Foster MC, Wood WA, Bailey C, Hackney AC, Mayer DK, Muss HB, Reeve BB (2018) The effects of exercise on patient-reported outcomes and performance-based physical function in adults with acute leukemia undergoing induction therapy: exercise and quality of life in acute leukemia (EQUAL). Integr Cancer Ther 17:263–270. https://doi.org/10.1177/1534735417699881CrossRefPubMed

24.

Burgomaster KA, Howarth KR, Phillips SM, Rakobowchuk M, Macdonald MJ, McGee SL, Gibala MJ (2008) Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol 586:151–160. https://doi.org/10.1113/jphysiol.2007.142109CrossRefPubMed

25.

Burtscher J, Soltany A, Visavadiya NP, Burtscher M, Millet GP, Khoramipour K, Khamoui AV (2023) Mitochondrial stress and mitokines in aging. Aging Cell 22:e13770. https://doi.org/10.1111/acel.13770CrossRefPubMedPubMedCentral

26.

Bye A, Sandmael JA, Stene GB, Thorsen L, Balstad TR, Solheim TS, Pripp AH, Oldervoll LM (2020) Exercise and nutrition interventions in patients with head and neck cancer during curative treatment: a systematic review and meta-analysis. Nutrients. https://doi.org/10.3390/nu12113233CrossRefPubMedPubMedCentral

27.

Campodonico J, Contini M, Alimento M, Mapelli M, Salvioni E, Mattavelli I, Bonomi A, Agostoni P (2023) Physiology of exercise and heart failure treatments: cardiopulmonary exercise testing as a tool for choosing the optimal therapeutic strategy. Eur J Prev Cardiol 30:ii54–ii62. https://doi.org/10.1093/eurjpc/zwad189CrossRefPubMed

28.

Cardaci S, Zheng L, MacKay G, van den Broek NJ, MacKenzie ED, Nixon C, Stevenson D, Tumanov S, Bulusu V, Kamphorst JJ, Vazquez A, Fleming S, Schiavi F, Kalna G, Blyth K, Strathdee D, Gottlieb E (2015) Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat Cell Biol 17:1317–1326. https://doi.org/10.1038/ncb3233CrossRefPubMedPubMedCentral

29.

Cavalheri V, Burtin C, Formico VR, Nonoyama ML, Jenkins S, Spruit MA, Hill K (2019) Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Cochrane Database Syst Rev 6:Cd009955. https://doi.org/10.1002/14651858.CD009955.pub3CrossRefPubMed

30.

Chiang PH, Wong M, Dey S (2021) Using wearables and machine learning to enable personalized lifestyle recommendations to improve blood pressure. IEEE J Transl Eng Health Med 9:2700513. https://doi.org/10.1109/jtehm.2021.3098173CrossRefPubMed

31.

Chiaranda G, Myers J, Arena R, Kaminsky L, Sassone B, Pasanisi G, Mandini S, Mazzoni G, Grazzi G (2021) Prognostic comparison of the FRIEND and Wasserman/Hansen peak VO2 equations applied to a submaximal walking test in outpatients with cardiovascular disease. Eur J Prev Cardiol 28:287–292. https://doi.org/10.1177/2047487319871728CrossRefPubMed

32.

Chicco AJ, Schneider CM, Hayward R (2006) Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol 47:182–189. https://doi.org/10.1097/01.fjc.0000199682.43448.2dCrossRefPubMed

33.

Chung IY, Jung M, Park YR, Cho D, Chung H, Min YH, Park HJ, Lee M, Lee SB, Chung S, Son BH, Ahn SH, Lee JW (2019) Exercise promotion and distress reduction using a mobile app-based community in breast cancer survivors. Front Oncol 9:1505. https://doi.org/10.3389/fonc.2019.01505CrossRefPubMed

34.

Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M (2002) A non-invasively determined surrogate of cardiac power ('circulatory power’) at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J 23:806–814. https://doi.org/10.1053/euhj.2001.2966CrossRefPubMed

35.

Colbert LH, Westerlind KC, Perkins SN, Haines DC, Berrigan D, Donehower LA, Fuchs-Young R, Hursting SD (2009) Exercise effects on tumorigenesis in a p53-deficient mouse model of breast cancer. Med Sci Sports Exerc 41:1597–1605. https://doi.org/10.1249/MSS.0b013e31819f1f05CrossRefPubMedPubMedCentral

36.

Cormie P, Galvão DA, Spry N, Joseph D, Chee R, Taaffe DR, Chambers SK, Newton RU (2015) Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int 115:256–266. https://doi.org/10.1111/bju.12646CrossRefPubMed

37.

Courneya KS, McKenzie DC, Mackey JR, Gelmon K, Friedenreich CM, Yasui Y, Reid RD, Cook D, Jespersen D, Proulx C, Dolan LB, Forbes CC, Wooding E, Trinh L, Segal RJ (2013) Effects of exercise dose and type during breast cancer chemotherapy: multicenter randomized trial. J Natl Cancer Inst 105:1821–1832. https://doi.org/10.1093/jnci/djt297CrossRefPubMed

38.

Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, Tankel K, Basi S, Chua N, Mazurek A, Reiman T (2009) Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol 27:4605–4612. https://doi.org/10.1200/jco.2008.20.0634CrossRefPubMed

39.

D’Ascenzi F, Anselmi F, Fiorentini C, Mannucci R, Bonifazi M, Mondillo S (2021) The benefits of exercise in cancer patients and the criteria for exercise prescription in cardio-oncology. Eur J Prev Cardiol 28:725–735. https://doi.org/10.1177/2047487319874900CrossRefPubMed

40.

Dembrower K, Crippa A, Colón E, Eklund M, Strand F (2023) Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study. Lancet Digit Health 5:e703–e711. https://doi.org/10.1016/s2589-7500(23)00153-xCrossRefPubMed

41.

Ellingsen Ø, Halle M, Conraads V, Støylen A, Dalen H, Delagardelle C, Larsen AI, Hole T, Mezzani A, Van Craenenbroeck EM, Videm V, Beckers P, Christle JW, Winzer E, Mangner N, Woitek F, Höllriegel R, Pressler A, Monk-Hansen T, Snoer M, Feiereisen P, Valborgland T, Kjekshus J, Hambrecht R, Gielen S, Karlsen T, Prescott E, Linke A (2017) High-intensity interval training in patients with heart failure with reduced ejection fraction. Circulation 135:839–849. https://doi.org/10.1161/circulationaha.116.022924CrossRefPubMedPubMedCentral

42.

Ester M, Wagoner CW, Dreger J, Chen G, McDonough MH, McNeely ML, Culos-Reed SN (2023) Effectiveness of a self-monitoring app in supporting physical activity maintenance among rural canadians with cancer after an exercise oncology program: cluster randomized controlled trial. JMIR Cancer 9:e47187. https://doi.org/10.2196/47187CrossRefPubMedPubMedCentral

43.

Fadol AP, Mouhayar E, Reyes-Gibby CC (2017) The use of cardiac resynchronization therapy in cancer patients with heart failure. J Clin Exp Res Cardiol. https://doi.org/10.15744/2394-6504.3.105CrossRefPubMedPubMedCentral

44.

Fardman A, Banschick GD, Rabia R, Percik R, Fourey D, Segev S, Klempfner R, Grossman E, Maor E (2021) Cardiorespiratory fitness and survival following cancer diagnosis. Eur J Prev Cardiol 28:1242–1249. https://doi.org/10.1177/2047487320930873CrossRefPubMed

45.

Farrar GJ, Chadderton N, Kenna PF, Millington-Ward S (2013) Mitochondrial disorders: aetiologies, models systems, and candidate therapies. Trends Genet 29:488–497. https://doi.org/10.1016/j.tig.2013.05.005CrossRefPubMed

46.

Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495. https://doi.org/10.1016/s1470-2045(10)70218-7CrossRefPubMed

47.

Finke D, Heckmann MB, Wilhelm S, Entenmann L, Hund H, Bougatf N, Katus HA, Frey N, Lehmann LH (2023) Coronary artery disease, left ventricular function and cardiac biomarkers determine all-cause mortality in cancer patients-a large monocenter cohort study. Clin Res Cardiol 112:203–214. https://doi.org/10.1007/s00392-022-02001-6CrossRefPubMed

48.

Fitzgerald MD, Tanaka H, Tran ZV, Seals DR (1997) Age-related declines in maximal aerobic capacity in regularly exercising vs. sedentary women: a meta-analysis. J Appl Physiol 83:160–165. https://doi.org/10.1152/jappl.1997.83.1.160CrossRefPubMed

49.

Forman DE, Guazzi M, Myers J, Chase P, Bensimhon D, Cahalin LP, Peberdy MA, Ashley E, West E, Daniels KM, Arena R (2012) Ventilatory power: a novel index that enhances prognostic assessment of patients with heart failure. Circ Heart Fail 5:621–626. https://doi.org/10.1161/circheartfailure.112.968529CrossRefPubMedPubMedCentral

50.

Foulkes SJ, Howden EJ, Antill Y, Loi S, Salim A, Haykowsky MJ, Daly RM, Fraser SF, La Gerche A (2020) Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients- the BReast cancer EXercise InTervention (BREXIT) trial protocol. BMC Cancer 20:655. https://doi.org/10.1186/s12885-020-07123-6CrossRefPubMedPubMedCentral

51.

Foulkes SJ, Howden EJ, Bigaran A, Janssens K, Antill Y, Loi S, Claus P, Haykowsky MJ, Daly RM, Fraser SF (2019) Persistent impairment in cardiopulmonary fitness after breast cancer chemotherapy. Med Sci Sports Exerc 51:1573–1581. https://doi.org/10.1249/mss.0000000000001970CrossRefPubMed

52.

Foulkes SJ, Howden EJ, Haykowsky MJ, Antill Y, Salim A, Nightingale SS, Loi S, Claus P, Janssens K, Mitchell AM, Wright L, Costello BT, Lindqvist A, Burnham L, Wallace I, Daly RM, Fraser SF, La Gerche A (2023) Exercise for the prevention of anthracycline-induced functional disability and cardiac dysfunction: the BREXIT study. Circulation 147:532–545. https://doi.org/10.1161/circulationaha.122.062814CrossRefPubMed

53.

Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB (2017) Multi-institutional assessment of adverse health outcomes among north american testicular cancer survivors after modern cisplatin-based chemotherapy. J Clin Oncol 35:1211–1222. https://doi.org/10.1200/jco.2016.70.3108CrossRefPubMedPubMedCentral

54.

Gaglio D, Metallo CM, Gameiro PA, Hiller K, Danna LS, Balestrieri C, Alberghina L, Stephanopoulos G, Chiaradonna F (2011) Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol 7:523. https://doi.org/10.1038/msb.2011.56CrossRefPubMedPubMedCentral

55.

Gaude E, Frezza C (2014) Defects in mitochondrial metabolism and cancer. Cancer Metab 2:10. https://doi.org/10.1186/2049-3002-2-10CrossRefPubMedPubMedCentral

56.

Gautam N, Ghanta SN, Mueller J, Mansour M, Chen Z, Puente C, Ha YM, Tarun T, Dhar G, Sivakumar K, Zhang Y, Halimeh AA, Nakarmi U, Al-Kindi S, DeMazumder D, Al’Aref SJ (2022) Artificial intelligence wearables and remote monitoring for heart failure: current and future applications. Diagnostics (Basel). https://doi.org/10.3390/diagnostics12122964CrossRefPubMed

57.

Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, La Gerche A, Ligibel JA, Lopez G, Madan K, Oeffinger KC, Salamone J, Scott JM, Squires RW, Thomas RJ, Treat-Jacobson DJ, Wright JS (2019) Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from The American Heart Association. Circulation 139:e997–e1012. https://doi.org/10.1161/cir.0000000000000679CrossRefPubMedPubMedCentral

58.

Goh LG, Welborn TA, Dhaliwal SS (2014) Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study. BMC Womens Health 14:118. https://doi.org/10.1186/1472-6874-14-118CrossRefPubMedPubMedCentral

59.

Gomes Neto M, Durães AR, Conceição LSR, Saquetto MB, Ellingsen Ø, Carvalho VO (2018) High intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis. Int J Cardiol 261:134–141. https://doi.org/10.1016/j.ijcard.2018.02.076CrossRefPubMed

60.

Gordon JW, Rungi AA, Inagaki H (1985) Hood DA (2001) Effects of contractile activity on mitochondrial transcription factor A expression in skeletal muscle. J Appl Physiol 90:389–396. https://doi.org/10.1152/jappl.2001.90.1.389CrossRef

61.

Groarke JD, Payne DL, Claggett B, Mehra MR, Gong J, Caron J, Mahmood SS, Hainer J, Neilan TG, Partridge AH, Di Carli M, Jones LW, Nohria A (2020) Association of post-diagnosis cardiorespiratory fitness with cause-specific mortality in cancer. Eur Heart J Qual Care Clin Outcomes 6:315–322. https://doi.org/10.1093/ehjqcco/qcaa015CrossRefPubMedPubMedCentral

62.

Guazzi M, Arena R, Halle M, Piepoli MF, Myers J, Lavie CJ (2018) 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 39:1144–1161. https://doi.org/10.1093/eurheartj/ehw180CrossRefPubMed

63.

Guazzi M, Wilhelm M, Halle M, Van Craenenbroeck E, Kemps H, de Boer RA, Coats AJS, Lund L, Mancini D, Borlaug B, Filippatos G, Pieske B (2022) Exercise testing in heart failure with preserved ejection fraction: an appraisal through diagnosis, pathophysiology and therapy - A clinical consensus statement of the Heart Failure Association and European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Heart Fail 24:1327–1345. https://doi.org/10.1002/ejhf.2601CrossRefPubMed

64.

Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M (2016) The utility of exercise testing in patients with lung cancer. J Thorac Oncol 11:1397–1410. https://doi.org/10.1016/j.jtho.2016.04.021CrossRefPubMedPubMedCentral

65.

Hadzibegovic S, Porthun J, Lena A, Weinländer P, Lück LC, Potthoff SK, Rösnick L, Fröhlich AK, Ramer LV, Sonntag F, Wilkenshoff U, Ahn J, Keller U, Bullinger L, Mahabadi AA, Totzeck M, Rassaf T, von Haehling S, Coats AJS, Anker SD, Roeland EJ, Landmesser U, Anker MS (2023) Hand grip strength in patients with advanced cancer: a prospective study. J Cachexia Sarcopenia Muscle 14:1682–1694. https://doi.org/10.1002/jcsm.13248CrossRefPubMedPubMedCentral

66.

Hansen JE, Sue DY, Wasserman K (1984) Predicted values for clinical exercise testing. Am Rev Respir Dis 129:S49-55. https://doi.org/10.1164/arrd.1984.129.2P2.S49CrossRefPubMed

67.

Hayes SCSM, Spence R, Pyke C, Saunders C, Bashford J, Eakin E (2017) Can exercise influence survival following breast cancer: results from a randomised, controlled trial. J Clin Oncol 35:S10067–S10067. https://doi.org/10.1200/JCO.2017.35.15_suppl.10067CrossRef

68.

Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW (2011) Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 58:265–274. https://doi.org/10.1016/j.jacc.2011.02.055CrossRefPubMedPubMedCentral

69.

Haykowsky MJ, Mackey JR, Thompson RB, Jones LW, Paterson DI (2009) Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res 15:4963–4967. https://doi.org/10.1158/1078-0432.Ccr-09-0628CrossRefPubMed

70.

Heusch G (2023) Cardioprotection in cardio-oncology: a case for concern? Cardiovasc Res 119:e144–e145. https://doi.org/10.1093/cvr/cvad111CrossRefPubMed

71.

Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17:773–789. https://doi.org/10.1038/s41569-020-0403-yCrossRefPubMed

72.

Heusch G, Rassaf T (2021) Protection from cardiotoxicity of cancer chemotherapy: a novel target for remote ischaemic conditioning? Cardiovasc Res 117:985–986. https://doi.org/10.1093/cvr/cvaa199CrossRefPubMed

73.

Hinrichs L, Mrotzek SM, Mincu RI, Pohl J, Röll A, Michel L, Mahabadi AA, Al-Rashid F, Totzeck M, Rassaf T (2020) Troponins and natriuretic peptides in cardio-oncology patients-data from the ECoR registry. Front Pharmacol 11:740. https://doi.org/10.3389/fphar.2020.00740CrossRefPubMedPubMedCentral

74.

Hofmann P, Von Duvillard SP, Seibert FJ, Pokan R, Wonisch M, Lemura LM, Schwaberger G (2001) %HRmax target heart rate is dependent on heart rate performance curve deflection. Med Sci Sports Exerc 33:1726–1731. https://doi.org/10.1097/00005768-200110000-00017CrossRefPubMed

75.

Holloszy JO (1967) Biochemical adaptations in muscle. Effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. J Biol Chem 242:2278–2282CrossRefPubMed

76.

Holloway GP (2017) Nutrition and training influences on the regulation of mitochondrial adenosine diphosphate sensitivity and bioenergetics. Sports Med 47:13–21. https://doi.org/10.1007/s40279-017-0693-3CrossRefPubMedPubMedCentral

77.

Hood DA, Memme JM, Oliveira AN, Triolo M (2019) Maintenance of skeletal muscle mitochondria in health, exercise, and aging. Annu Rev Physiol 81:19–41. https://doi.org/10.1146/annurev-physiol-020518-114310CrossRefPubMed

78.

Howden EJ, Bigaran A, Beaudry R, Fraser S, Selig S, Foulkes S, Antill Y, Nightingale S, Loi S, Haykowsky MJ, La Gerche A (2019) Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients. Eur J Prev Cardiol 26:305–315. https://doi.org/10.1177/2047487318811181CrossRefPubMed

79.

Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS, Escribano-Subias P, Ferrari P, Ferreira DS, Ghofrani HA, Giannakoulas G, Kiely DG, Mayer E, Meszaros G, Nagavci B, Olsson KM, Pepke-Zaba J, Quint JK, Rådegran G, Simonneau G, Sitbon O, Tonia T, Toshner M, Vachiery JL, Vonk Noordegraaf A, Delcroix M, Rosenkranz S (2022) 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43:3618–3731. https://doi.org/10.1093/eurheartj/ehac237CrossRefPubMed

80.

Hurria A, Jones L, Muss HB (2016) Cancer treatment as an accelerated aging process: assessment, biomarkers, and interventions. Am Soc Clin Oncol Educ Book 35:e516-522. https://doi.org/10.1200/edbk_156160CrossRefPubMed

81.

Irrcher I, Ljubicic V, Hood DA (2009) Interactions between ROS and AMP kinase activity in the regulation of PGC-1alpha transcription in skeletal muscle cells. Am J Physiol Cell Physiol 296:C116-123. https://doi.org/10.1152/ajpcell.00267.2007CrossRefPubMed

82.

Irwin ML, Cartmel B, Gross CP, Ercolano E, Li F, Yao X, Fiellin M, Capozza S, Rothbard M, Zhou Y, Harrigan M, Sanft T, Schmitz K, Neogi T, Hershman D, Ligibel J (2015) Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 33:1104–1111. https://doi.org/10.1200/jco.2014.57.1547CrossRefPubMed

83.

Foulkes SJ, Haykowsky MJ, Li T, Wang J, Kennedy M, Kirkham AA, Thompson RB, Ian Paterson D, La Gerche A, Pituskin E (2023) Determinants of impaired peak oxygen uptake in breast cancer survivors. JACC CardioOncol. https://doi.org/10.1016/j.jaccao.2023.11.005CrossRef

84.

Jarden M, Hovgaard D, Boesen E, Quist M, Adamsen L (2007) Pilot study of a multimodal intervention: mixed-type exercise and psychoeducation in patients undergoing allogeneic stem cell transplantation. Bone Marrow Transplant 40:793–800. https://doi.org/10.1038/sj.bmt.1705807CrossRefPubMed

85.

Jones LW, Courneya KS, Mackey JR, Muss HB, Pituskin EN, Scott JM, Hornsby WE, Coan AD, Herndon JE 2nd, Douglas PS, Haykowsky M (2012) Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum. J Clin Oncol 30:2530–2537. https://doi.org/10.1200/jco.2011.39.9014CrossRefPubMedPubMedCentral

86.

Jones LW, Fels DR, West M, Allen JD, Broadwater G, Barry WT, Wilke LG, Masko E, Douglas PS, Dash RC, Povsic TJ, Peppercorn J, Marcom PK, Blackwell KL, Kimmick G, Turkington TG, Dewhirst MW (2013) Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res (Phila) 6:925–937. https://doi.org/10.1158/1940-6207.Capr-12-0416CrossRefPubMed

87.

Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, Kwan ML, Quesenberry CP Jr, Scott J, Sternfeld B, Yu A, Kushi LH, Caan BJ (2016) Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. J Clin Oncol 34:2743–2749. https://doi.org/10.1200/jco.2015.65.6603CrossRefPubMedPubMedCentral

88.

Ju J, Nolan B, Cheh M, Bose M, Lin Y, Wagner GC, Yang CS (2008) Voluntary exercise inhibits intestinal tumorigenesis in Apc(Min/+) mice and azoxymethane/dextran sulfate sodium-treated mice. BMC Cancer 8:316. https://doi.org/10.1186/1471-2407-8-316CrossRefPubMedPubMedCentral

89.

Kalkan A, Metze C, Iliadis C, Körber MI, Baldus S, Pfister R (2023) Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair. Clin Res Cardiol. https://doi.org/10.1007/s00392-023-02266-5CrossRefPubMedPubMedCentral

90.

Kaminsky LA, Arena R, Beckie TM, Brubaker PH, Church TS, Forman DE, Franklin BA, Gulati M, Lavie CJ, Myers J, Patel MJ, Piña IL, Weintraub WS, Williams MA (2013) The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation 127:652–662. https://doi.org/10.1161/CIR.0b013e31827ee100CrossRefPubMed

91.

Karsli-Uzunbas G, Guo JY, Price S, Teng X, Laddha SV, Khor S, Kalaany NY, Jacks T, Chan CS, Rabinowitz JD, White E (2014) Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov 4:914–927. https://doi.org/10.1158/2159-8290.Cd-14-0363CrossRefPubMedPubMedCentral

92.

Kaszak I, Witkowska-Piłaszewicz O, Niewiadomska Z, Dworecka-Kaszak B, Ngosa Toka F, Jurka P (2020) Role of cadherins in cancer-a review. Int J Mol Sci. https://doi.org/10.3390/ijms21207624CrossRefPubMedPubMedCentral

93.

Kersting D, Mavroeidi IA, Settelmeier S, Seifert R, Schuler M, Herrmann K, Rassaf T, Rischpler C (2023) Molecular imaging biomarkers in cardiooncology: a view on established technologies and future perspectives. J Nucl Med 64:29s–38s. https://doi.org/10.2967/jnumed.122.264868CrossRefPubMed

94.

Khan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos AP, Georgiopoulou VV, Butler J, Laukkanen JA (2014) Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study. Eur J Heart Fail 16:180–188. https://doi.org/10.1111/ejhf.37CrossRefPubMed

95.

Kim Y, Triolo M, Erlich AT, Hood DA (2019) Regulation of autophagic and mitophagic flux during chronic contractile activity-induced muscle adaptations. Pflugers Arch 471:431–440. https://doi.org/10.1007/s00424-018-2225-xCrossRefPubMed

96.

Kirkham AA, Bonsignore A, Bland KA, McKenzie DC, Gelmon KA, CL VANP, Campbell KL, (2018) Exercise prescription and adherence for breast cancer: one size does not FITT All. Med Sci Sports Exerc 50:177–186. https://doi.org/10.1249/mss.0000000000001446CrossRefPubMed

97.

Kirkham AA, Eves ND, Shave RE, Bland KA, Bovard J, Gelmon KA, Virani SA, McKenzie DC, Stöhr EJ, Waburton DER, Campbell KL (2018) The effect of an aerobic exercise bout 24 h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res Treat 167:719–729. https://doi.org/10.1007/s10549-017-4554-4CrossRefPubMed

98.

Kirkham AA, Paterson DI, Prado CM, Mackey JR, Courneya KS, Pituskin E, Thompson RB (2018) Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer. BMC Cancer 18:864. https://doi.org/10.1186/s12885-018-4778-7CrossRefPubMedPubMedCentral

99.

Kirkham AA, Pituskin E, Mackey JR, Grenier JG, Ian Paterson D, Haykowsky MJ, Thompson RB (2022) Longitudinal changes in skeletal muscle metabolism, oxygen uptake, and myosteatosis during cardiotoxic treatment for early-stage breast cancer. Oncologist 27:e748–e754. https://doi.org/10.1093/oncolo/oyac092CrossRefPubMedPubMedCentral

100.

Kirkham AA, Shave RE, Bland KA, Bovard JM, Eves ND, Gelmon KA, McKenzie DC, Virani SA, Stöhr EJ, Warburton DER, Campbell KL (2017) Protective effects of acute exercise prior to doxorubicin on cardiac function of breast cancer patients: a proof-of-concept RCT. Int J Cardiol 245:263–270. https://doi.org/10.1016/j.ijcard.2017.07.037CrossRefPubMed

101.

Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H (2009) Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301:2024–2035. https://doi.org/10.1001/jama.2009.681CrossRefPubMed

102.

Korste S, Settelmeier S, Michel L, Odersky A, Stock P, Reyes F, Haj-Yehia E, Anker MS, Grüneboom A, Hendgen-Cotta UB, Rassaf T, Totzeck M (2023) Anthracycline therapy modifies immune checkpoint signaling in the heart. Int J Mol Sci. https://doi.org/10.3390/ijms24076052CrossRefPubMedPubMedCentral

103.

Kwan G, Balady GJ (2012) Cardiac rehabilitation 2012: advancing the field through emerging science. Circulation 125:e369-373. https://doi.org/10.1161/circulationaha.112.093310CrossRefPubMed

104.

La Gerche A, Howden EJ, Haykowsky MJ, Lewis GD, Levine BD, Kovacic JC (2022) Heart failure with preserved ejection fraction as an exercise deficiency syndrome: JACC focus seminar 2/4. J Am Coll Cardiol 80:1177–1191. https://doi.org/10.1016/j.jacc.2022.07.011CrossRefPubMed

105.

Lahart IM, Metsios GS, Nevill AM, Carmichael AR (2015) Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol 54:635–654. https://doi.org/10.3109/0284186x.2014.998275CrossRefPubMed

106.

Laker RC, Drake JC, Wilson RJ, Lira VA, Lewellen BM, Ryall KA, Fisher CC, Zhang M, Saucerman JJ, Goodyear LJ, Kundu M, Yan Z (2017) Ampk phosphorylation of Ulk1 is required for targeting of mitochondria to lysosomes in exercise-induced mitophagy. Nat Commun 8:548. https://doi.org/10.1038/s41467-017-00520-9ADSCrossRefPubMedPubMedCentral

107.

Lakoski SG, Eves ND, Douglas PS, Jones LW (2012) Exercise rehabilitation in patients with cancer. Nat Rev Clin Oncol 9:288–296. https://doi.org/10.1038/nrclinonc.2012.27CrossRefPubMedPubMedCentral

108.

Lång K, Josefsson V, Larsson AM, Larsson S, Högberg C, Sartor H, Hofvind S, Andersson I, Rosso A (2023) Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study. Lancet Oncol 24:936–944. https://doi.org/10.1016/s1470-2045(23)00298-xCrossRefPubMed

109.

Lawler M, Davies L, Oberst S, Oliver K, Eggermont A, Schmutz A, La Vecchia C, Allemani C, Lievens Y, Naredi P, Cufer T, Aggarwal A, Aapro M, Apostolidis K, Baird AM, Cardoso F, Charalambous A, Coleman MP, Costa A, Crul M, Dégi CL, Di Nicolantonio F, Erdem S, Geanta M, Geissler J, Jassem J, Jagielska B, Jonsson B, Kelly D, Kelm O, Kolarova T, Kutluk T, Lewison G, Meunier F, Pelouchova J, Philip T, Price R, Rau B, Rubio IT, Selby P, Južnič Sotlar M, Spurrier-Bernard G, van Hoeve JC, Vrdoljak E, Westerhuis W, Wojciechowska U, Sullivan R (2023) European Groundshot-addressing Europe’s cancer research challenges: a Lancet Oncology Commission. Lancet Oncol 24:e11–e56. https://doi.org/10.1016/s1470-2045(22)00540-xCrossRefPubMed

110.

Lee K, Tripathy D, Demark-Wahnefried W, Courneya KS, Sami N, Bernstein L, Spicer D, Buchanan TA, Mortimer JE, Dieli-Conwright CM (2019) Effect of aerobic and resistance exercise intervention on cardiovascular disease risk in women with early-stage breast cancer: a randomized clinical trial. JAMA Oncol 5:710–714. https://doi.org/10.1001/jamaoncol.2019.0038CrossRefPubMedPubMedCentral

111.

Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS (2017) Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 16:10. https://doi.org/10.1186/s12943-016-0577-4CrossRefPubMedPubMedCentral

112.

Lehmann LH, Cautela J, Palaskas N, Baik AH, Meijers WC, Allenbach Y, Alexandre J, Rassaf T, Müller OJ, Aras M, Asnani AH, Deswal A, Laufer-Perl M, Thuny F, Kerneis M, Hayek SS, Ederhy S, Salem JE, Moslehi JJ (2021) Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor-associated myocarditis: a narrative review. JAMA Cardiol 6:1329–1337. https://doi.org/10.1001/jamacardio.2021.2241CrossRefPubMed

113.

Lehmann LH, Stein F, Jäger D, Frey N (2022) The Heidelberg cardio-oncology unit (COUNT)-a possible blueprint for improved care of cardio-oncological patients. Clin Res Cardiol 111:227–229. https://doi.org/10.1007/s00392-021-01894-zCrossRefPubMed

114.

Lena A, Wilkenshoff U, Hadzibegovic S, Porthun J, Rösnick L, Fröhlich AK, Zeller T, Karakas M, Keller U, Ahn J, Bullinger L, Riess H, Rosen SD, Lyon AR, Lüscher TF, Totzeck M, Rassaf T, Burkhoff D, Mehra MR, Bax JJ, Butler J, Edelmann F, Haverkamp W, Anker SD, Packer M, Coats AJS, von Haehling S, Landmesser U, Anker MS (2023) Clinical and prognostic relevance of cardiac wasting in patients with advanced cancer. J Am Coll Cardiol 81:1569–1586. https://doi.org/10.1016/j.jacc.2023.02.039CrossRefPubMed

115.

Leung PS, Aronson WJ, Ngo TH, Golding LA, Barnard RJ (2004) Exercise alters the IGF axis in vivo and increases protein in prostate tumor cells in vitro. J Appl Physiol 96:450–454. https://doi.org/10.1152/japplphysiol.00871.2003CrossRefPubMed

116.

Lind A, Totzeck M, Mahabadi AA, Jánosi RA, El Gabry M, Ruhparwar A, Mrotzek SM, Hinrichs L, Akdeniz M, Rassaf T, Mincu RI (2020) Impact of cancer in patients undergoing transcatheter aortic valve replacement: a single-center study. JACC CardioOncol 2:735–743. https://doi.org/10.1016/j.jaccao.2020.11.008CrossRefPubMedPubMedCentral

117.

Linehan WM, Srinivasan R, Garcia JA (2013) Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches. Semin Oncol 40:511–520. https://doi.org/10.1053/j.seminoncol.2013.05.009CrossRefPubMedPubMedCentral

118.

Lipsett A, Barrett S, Haruna F, Mustian K, O’Donovan A (2017) The impact of exercise during adjuvant radiotherapy for breast cancer on fatigue and quality of life: a systematic review and meta-analysis. Breast 32:144–155. https://doi.org/10.1016/j.breast.2017.02.002CrossRefPubMed

119.

Liu Y, Sun Y, Guo Y, Shi X, Chen X, Feng W, Wu LL, Zhang J, Yu S, Wang Y, Shi Y (2023) An overview: the diversified role of mitochondria in cancer metabolism. Int J Biol Sci 19:897–915. https://doi.org/10.7150/ijbs.81609CrossRefPubMedPubMedCentral

120.

Lonardo E, Cioffi M, Sancho P, Sanchez-Ripoll Y, Trabulo SM, Dorado J, Balic A, Hidalgo M, Heeschen C (2013) Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. PLoS ONE 8:e76518. https://doi.org/10.1371/journal.pone.0076518ADSCrossRefPubMedPubMedCentral

121.

Lundby C, Jacobs RA (2016) Adaptations of skeletal muscle mitochondria to exercise training. Exp Physiol 101:17–22. https://doi.org/10.1113/ep085319CrossRefPubMed

122.

Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH (2022) 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43:4229–4361. https://doi.org/10.1093/eurheartj/ehac244CrossRefPubMed

123.

MacInnis MJ, Gibala MJ (2017) Physiological adaptations to interval training and the role of exercise intensity. J Physiol 595:2915–2930. https://doi.org/10.1113/jp273196CrossRefPubMed

124.

Malhotra R, Bakken K, D’Elia E, Lewis GD (2016) Cardiopulmonary exercise testing in heart failure. JACC Heart Fail 4:607–616. https://doi.org/10.1016/j.jchf.2016.03.022CrossRefPubMed

125.

Mapelli M, Salvioni E, Mattavelli I, Gugliandolo P, Bonomi A, Palermo P, Rossi M, Stolfo D, Gustafsson F, Piepoli M, Agostoni P (2023) Activities of daily living in heart failure patients and healthy subjects: when the cardiopulmonary assessment goes beyond traditional exercise test protocols. Eur J Prev Cardiol 30:ii47–ii53. https://doi.org/10.1093/eurjpc/zwad155CrossRefPubMed

126.

Marriott CFS, Petrella AFM, Marriott ECS, Boa Sorte Silva NC, Petrella RJ (2021) High-intensity interval training in older adults: a scoping review. Sports Med Open 7:49. https://doi.org/10.1186/s40798-021-00344-4CrossRefPubMedPubMedCentral

127.

Martín-Payo R, Martínez-Urquijo A, Zabaleta-Del-Olmo E, Del Mar F-A (2023) Use a web-app to improve breast cancer risk factors and symptoms knowledge and adherence to healthy diet and physical activity in women without breast cancer diagnosis (Precam project). Cancer Causes Control 34:113–122. https://doi.org/10.1007/s10552-022-01647-xCrossRefPubMed

128.

Mattavelli I, Vignati C, Farina S, Apostolo A, Cattadori G, De Martino F, Pezzuto B, Zaffalon D, Agostoni P (2023) Beyond VO2: the complex cardiopulmonary exercise test. Eur J Prev Cardiol 30:ii34–ii39. https://doi.org/10.1093/eurjpc/zwad154CrossRefPubMed

129.

Mattioli R, Ilari A, Colotti B, Mosca L, Fazi F, Colotti G (2023) Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming. Mol Aspects Med 93:101205. https://doi.org/10.1016/j.mam.2023.101205CrossRefPubMed

130.

McDonald J, Sayers J, Anker SD, Arends J, Balstad TR, Baracos V, Brown L, Bye A, Dajani O, Dolan R, Fallon MT, Fraser E, Griel C, Grzyb A, Hjermstad M, Jamal-Hanjani M, Jakobsen G, Kaasa S, McMillan D, Maddocks M, Philips I, Ottestad IO, Reid KF, Sousa MS, Simpson MR, Vagnildhaug OM, Skipworth RJE, Solheim TS, Laird BJA (2023) Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series. J Cachexia Sarcopenia Muscle 14:1932–1948. https://doi.org/10.1002/jcsm.13321CrossRefPubMedPubMedCentral

131.

Meyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24:3535–3541. https://doi.org/10.1200/jco.2006.06.0863CrossRefPubMed

132.

Michalski M, Rowed K, Lavery JA, Moskowitz CS, Capaci C, Stene G, Edvardsen E, Eves ND, Jones LW, Scott JM (2022) Validity of estimated cardiorespiratory fitness in patients with primary breast cancer. JACC CardioOncol 4:210–219. https://doi.org/10.1016/j.jaccao.2022.05.003CrossRefPubMedPubMedCentral

133.

Michel L, Helfrich I, Hendgen-Cotta UB, Mincu RI, Korste S, Mrotzek SM, Spomer A, Odersky A, Rischpler C, Herrmann K, Umutlu L, Coman C, Ahrends R, Sickmann A, Löffek S, Livingstone E, Ugurel S, Zimmer L, Gunzer M, Schadendorf D, Totzeck M, Rassaf T (2022) Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy. Eur Heart J 43:316–329. https://doi.org/10.1093/eurheartj/ehab430CrossRefPubMed

134.

Michel L, Mincu RI, Mahabadi AA, Settelmeier S, Al-Rashid F, Rassaf T, Totzeck M (2020) Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients: a meta-analysis. Eur J Heart Fail 22:350–361. https://doi.org/10.1002/ejhf.1631CrossRefPubMed

135.

Michel L, Mincu RI, Mrotzek SM, Korste S, Neudorf U, Rassaf T, Totzeck M (2020) Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis. ESC Heart Fail 7:423–433. https://doi.org/10.1002/ehf2.12589CrossRefPubMedPubMedCentral

136.

Michel L, Rassaf T, Totzeck M (2018) Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity. J Thorac Dis 10:S4282-s4295. https://doi.org/10.21037/jtd.2018.08.15CrossRefPubMedPubMedCentral

137.

Michel L, Rassaf T, Totzeck M (2019) Cardiotoxicity from immune checkpoint inhibitors. Int J Cardiol Heart Vasc 25:100420. https://doi.org/10.1016/j.ijcha.2019.100420CrossRefPubMedPubMedCentral

138.

Mijwel S, Cardinale DA, Norrbom J, Chapman M, Ivarsson N, Wengström Y, Sundberg CJ, Rundqvist H (2018) Exercise training during chemotherapy preserves skeletal muscle fiber area, capillarization, and mitochondrial content in patients with breast cancer. Faseb J 32:5495–5505. https://doi.org/10.1096/fj.201700968RCrossRefPubMed

139.

Mijwel S, Jervaeus A, Bolam KA, Norrbom J, Bergh J, Rundqvist H, Wengström Y (2019) High-intensity exercise during chemotherapy induces beneficial effects 12 months into breast cancer survivorship. J Cancer Surviv 13:244–256. https://doi.org/10.1007/s11764-019-00747-zCrossRefPubMedPubMedCentral

140.

Milanović Z, Sporiš G, Weston M (2015) Effectiveness of high-intensity interval training (HIT) and continuous endurance training for VO2max improvements: a systematic review and meta-analysis of controlled trials. Sports Med 45:1469–1481. https://doi.org/10.1007/s40279-015-0365-0CrossRefPubMed

141.

Mincu RI, Mahabadi AA, Michel L, Mrotzek SM, Schadendorf D, Rassaf T, Totzeck M (2019) Cardiovascular adverse events associated with BRAF and MEK inhibitors: a systematic review and meta-analysis. JAMA Netw Open 2:e198890. https://doi.org/10.1001/jamanetworkopen.2019.8890CrossRefPubMedPubMedCentral

142.

Moreno-Suarez I, Scheer A, Lam K, Dembo L, Spence AL, Hayward C, Kaye DM, Leet A, Fuller LM, Jacques A, Naylor LH, Green DJ, Maiorana A (2020) High-intensity interval training in patients with left ventricular assist devices: a pilot randomized controlled trial. J Heart Lung Transplant 39:1380–1388. https://doi.org/10.1016/j.healun.2020.08.005CrossRefPubMed

143.

Mrotzek SM, Lena A, Hadzibegovic S, Ludwig R, Al-Rashid F, Mahabadi AA, Mincu RI, Michel L, Johannsen L, Hinrichs L, Schuler M, Keller U, Anker SD, Landmesser U, Rassaf T, Anker MS, Totzeck M (2021) Assessment of coronary artery disease during hospitalization for cancer treatment. Clin Res Cardiol 110:200–210. https://doi.org/10.1007/s00392-020-01719-5CrossRefPubMed

144.

Myers J, Kaminsky LA, Lima R, Christle JW, Ashley E, Arena R (2017) A Reference equation for normal standards for VO(2) the fitness registry and the importance of exercise national database (FRIEND Registry). Prog Cardiovasc Dis 60:21–29. https://doi.org/10.1016/j.pcad.2017.03.002CrossRefPubMed

145.

Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE (2002) Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801. https://doi.org/10.1056/NEJMoa011858CrossRefPubMed

146.

Nagy AC, GulAcsi BP, CserEp Z, Hangody L, Forster T (2017) Late cardiac effect of anthracycline therapy in physically active breast cancer survivors - a prospective study. Neoplasma 64:92–100. https://doi.org/10.4149/neo_2017_111CrossRefPubMed

147.

Ohtani K, Fujino T, Ide T, Funakoshi K, Sakamoto I, Hiasa KI, Higo T, Kamezaki K, Akashi K, Tsutsui H (2019) Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity. Clin Res Cardiol 108:600–611. https://doi.org/10.1007/s00392-018-1386-0CrossRefPubMed

148.

Ojuka EO, Jones TE, Han DH, Chen M, Holloszy JO (2003) Raising Ca2+ in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. Faseb J 17:675–681. https://doi.org/10.1096/fj.02-0951comCrossRefPubMed

149.

Okwuosa TM, Ray RM, Palomo A, Foraker RE, Johnson L, Paskett ED, Caan B, Jones LW (2019) Pre-Diagnosis exercise and cardiovascular events in primary breast cancer: women’s health initiative. JACC CardioOncol 1:41–50. https://doi.org/10.1016/j.jaccao.2019.08.014CrossRefPubMedPubMedCentral

150.

Osman AF, Mehra MR, Lavie CJ, Nunez E, Milani RV (2000) The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 36:2126–2131. https://doi.org/10.1016/s0735-1097(00)00985-2CrossRefPubMed

151.

Palomo ARR, Johnson L, Paskett E, Caan B, Jones L, Okwuosa T (2017) Associations between exercise prior to and around the time of cancer diagnosis and subsequent cardiovascular events in women with breast cancer: a women’s health initiative (WHI) analysis. J Am Coll Cardiol 69(11):1774CrossRef

152.

Paschos KA, Canovas D, Bird NC (2009) The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal 21:665–674. https://doi.org/10.1016/j.cellsig.2009.01.006CrossRefPubMed

153.

Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, Johannesen HH, Becker JC, Pedersen KS, Dethlefsen C, Nielsen J, Gehl J, Pedersen BK, Thor Straten P, Hojman P (2016) Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab 23:554–562. https://doi.org/10.1016/j.cmet.2016.01.011CrossRefPubMed

154.

Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, Collet JP, Corrado D, Drezner JA, Halle M, Hansen D, Heidbuchel H, Myers J, Niebauer J, Papadakis M, Piepoli MF, Prescott E, Roos-Hesselink JW, Graham Stuart A, Taylor RS, Thompson PD, Tiberi M, Vanhees L, Wilhelm M (2021) 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 42:17–96. https://doi.org/10.1093/eurheartj/ehaa605CrossRefPubMed

155.

Peterman JE, Arena R, Myers J, Marzolini S, Ades PA, Savage PD, Lavie CJ, Kaminsky LA (2021) Reference standards for cardiorespiratory fitness by cardiovascular disease category and testing modality: data from FRIEND. J Am Heart Assoc 10:e022336. https://doi.org/10.1161/jaha.121.022336CrossRefPubMedPubMedCentral

156.

Peterson MD, Rhea MR, Alvar BA (2005) Applications of the dose-response for muscular strength development: a review of meta-analytic efficacy and reliability for designing training prescription. J Strength Cond Res 19:950–958. https://doi.org/10.1519/r-16874.1CrossRefPubMed

157.

Pituskin E, Cox-Kennett N, Foulkes S, Driga A, Dimitry R, Thompson RB, Kirkham A, Prado C, Gyenes G, Haykowsky MJ (2023) Cardio-oncology and cancer rehabilitation: is an integrated approach possible? Can J Cardiol. https://doi.org/10.1016/j.cjca.2023.09.024CrossRefPubMed

158.

Pohl J, Mincu RI, Mrotzek SM, Wakili R, Mahabadi AA, Potthoff SK, Siveke JT, Keller U, Landmesser U, Rassaf T, Anker MS, Totzeck M (2021) ECG scoring for the evaluation of therapy-naïve cancer patients to predict cardiotoxicity. Cancers (Basel). https://doi.org/10.3390/cancers13061197CrossRefPubMedPubMedCentral

159.

Popovic D, Arena R, Guazzi M (2018) A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction. Eur J Heart Fail 20:1115–1124. https://doi.org/10.1002/ejhf.1140CrossRefPubMed

160.

Porter C, Reidy PT, Bhattarai N, Sidossis LS, Rasmussen BB (2015) Resistance exercise training alters mitochondrial function in human skeletal muscle. Med Sci Sports Exerc 47:1922–1931. https://doi.org/10.1249/mss.0000000000000605CrossRefPubMedPubMedCentral

161.

Puterman E, Lin J, Blackburn E, O’Donovan A, Adler N, Epel E (2010) The power of exercise: buffering the effect of chronic stress on telomere length. PLoS ONE 5:e10837. https://doi.org/10.1371/journal.pone.0010837ADSCrossRefPubMedPubMedCentral

162.

Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, Visvanathan K (2021) All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. J Natl Cancer Inst 113:137–145. https://doi.org/10.1093/jnci/djaa096CrossRefPubMed

163.

Rashkis HA (1952) Systemic stress as an inhibitor of experimental tumors in Swiss mice. Science 116:169–171. https://doi.org/10.1126/science.116.3007.169ADSCrossRefPubMed

164.

Rassaf T, Totzeck M, Backs J, Bokemeyer C, Hallek M, Hilfiker-Kleiner D, Hochhaus A, Lüftner D, Müller OJ, Neudorf U, Pfister R, von Haehling S, Lehmann LH, Bauersachs J (2020) Onco-cardiology: consensus paper of the german cardiac society, the german society for pediatric cardiology and congenital heart defects and the german society for hematology and medical oncology. Clin Res Cardiol 109:1197–1222. https://doi.org/10.1007/s00392-020-01636-7CrossRefPubMedPubMedCentral

165.

Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM (2011) Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 71:3889–3895. https://doi.org/10.1158/0008-5472.Can-10-3932CrossRefPubMedPubMedCentral

166.

Rosenfeldt MT, O’Prey J, Morton JP, Nixon C, MacKay G, Mrowinska A, Au A, Rai TS, Zheng L, Ridgway R, Adams PD, Anderson KI, Gottlieb E, Sansom OJ, Ryan KM (2013) p53 status determines the role of autophagy in pancreatic tumour development. Nature 504:296–300. https://doi.org/10.1038/nature12865ADSCrossRefPubMed

167.

Sale DG (1987) Influence of exercise and training on motor unit activation. Exerc Sport Sci Rev 15:95–151CrossRefPubMed

168.

Samuel SR, Maiya AG, Fernandes DJ, Guddattu V, Saxena PUP, Kurian JR, Lin PJ, Mustian KM (2019) Effectiveness of exercise-based rehabilitation on functional capacity and quality of life in head and neck cancer patients receiving chemo-radiotherapy. Support Care Cancer 27:3913–3920. https://doi.org/10.1007/s00520-019-04750-zCrossRefPubMedPubMedCentral

169.

Samuel SR, Maiya GA, Babu AS, Vidyasagar MS (2013) Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy. Indian J Med Res 137:515–520PubMedPubMedCentral

170.

Sandmael JA, Bye A, Solheim TS, Stene GB, Thorsen L, Kaasa S, Lund J, Oldervoll LM (2017) Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: a pilot randomized trial. Cancer 123:4440–4448. https://doi.org/10.1002/cncr.30901CrossRefPubMed

171.

Sanoff HK, Deal AM, Krishnamurthy J, Torrice C, Dillon P, Sorrentino J, Ibrahim JG, Jolly TA, Williams G, Carey LA, Drobish A, Gordon BB, Alston S, Hurria A, Kleinhans K, Rudolph KL, Sharpless NE, Muss HB (2014) Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer. J Natl Cancer Inst 106:057. https://doi.org/10.1093/jnci/dju057CrossRef

172.

Santoro F, Tarantino N, Pellegrino PL, Caivano M, Lopizzo A, Di Biase M, Brunetti ND (2014) Cardiovascular sequelae of radiation therapy. Clin Res Cardiol 103:955–967. https://doi.org/10.1007/s00392-014-0718-yCrossRefPubMed

173.

Sasso JP, Eves ND, Christensen JF, Koelwyn GJ, Scott J, Jones LW (2015) A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle 6:115–124. https://doi.org/10.1002/jcsm.12042CrossRefPubMedPubMedCentral

174.

Scarpulla RC, Vega RB, Kelly DP (2012) Transcriptional integration of mitochondrial biogenesis. Trends Endocrinol Metab 23:459–466. https://doi.org/10.1016/j.tem.2012.06.006CrossRefPubMedPubMedCentral

175.

Scherr J, Wolfarth B, Christle JW, Pressler A, Wagenpfeil S, Halle M (2013) Associations between Borg’s rating of perceived exertion and physiological measures of exercise intensity. Eur J Appl Physiol 113:147–155. https://doi.org/10.1007/s00421-012-2421-xCrossRefPubMed

176.

Schmid D, Leitzmann MF (2014) Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol 25:1293–1311. https://doi.org/10.1093/annonc/mdu012CrossRefPubMed

177.

Scott JM, Nilsen TS, Gupta D, Jones LW (2018) Exercise therapy and cardiovascular toxicity in cancer. Circulation 137:1176–1191. https://doi.org/10.1161/circulationaha.117.024671CrossRefPubMedPubMedCentral

178.

Scott JM, Zabor EC, Schwitzer E, Koelwyn GJ, Adams SC, Nilsen TS, Moskowitz CS, Matsoukas K, Iyengar NM, Dang CT, Jones LW (2018) Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis. J Clin Oncol 36:2297–2305. https://doi.org/10.1200/jco.2017.77.5809CrossRefPubMedPubMedCentral

179.

Sebio Garcia R, Yáñez Brage MI, Giménez Moolhuyzen E, Granger CL, Denehy L (2016) Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 23:486–497. https://doi.org/10.1093/icvts/ivw152CrossRefPubMed

180.

Shephard RJ, Balady GJ (1999) Exercise as cardiovascular therapy. Circulation 99:963–972. https://doi.org/10.1161/01.cir.99.7.963CrossRefPubMed

181.

Siddiqi TJ, Rashid AM, Javaid SS, Siddiqi AK, Usman MS, Hervir O, Kamimura D, Lavie CJ, Mentz RJ, Butler J, Hall ME (2023) High-intensity interval training versus moderate continuous training in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis. Curr Probl Cardiol 48:101720. https://doi.org/10.1016/j.cpcardiol.2023.101720CrossRefPubMed

182.

Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33. https://doi.org/10.3322/caac.21708CrossRefPubMed

183.

Smarż K, Jaxa-Chamiec T, Chwyczko T, Główczyńska R, Jegier A, Niedoszytko P, Piotrowicz E, Rybicki J, Straburzyńska-Migaj E, Szalewska D, Szmit S, Wolszakiewicz J (2019) Cardiopulmonary exercise testing in adult cardiology: expert opinion of the working group of cardiac rehabilitation and exercise physiology of the polish cardiac society. Kardiol Pol 77:730–756. https://doi.org/10.33963/kp.14889CrossRefPubMed

184.

Squires RW, Shultz AM, Herrmann J (2018) Exercise training and cardiovascular health in cancer patients. Curr Oncol Rep 20:27. https://doi.org/10.1007/s11912-018-0681-2CrossRefPubMed

185.

Stewart JB, Alaei-Mahabadi B, Sabarinathan R, Samuelsson T, Gorodkin J, Gustafsson CM, Larsson E (2015) Simultaneous DNA and RNA mapping of somatic mitochondrial mutations across diverse human cancers. PLoS Genet 11:e1005333. https://doi.org/10.1371/journal.pgen.1005333CrossRefPubMedPubMedCentral

186.

Strasser B, Steindorf K, Wiskemann J, Ulrich CM (2013) Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 45:2080–2090. https://doi.org/10.1249/MSS.0b013e31829a3b63CrossRefPubMed

187.

Tabata N, Weber M, Sugiura A, Öztürk C, Tsujita K, Nickenig G, Sinning JM (2021) Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair. Clin Res Cardiol 110:440–450. https://doi.org/10.1007/s00392-020-01770-2CrossRefPubMed

188.

Tilemann LM, Heckmann MB, Katus HA, Lehmann LH, Müller OJ (2018) Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome. Clin Res Cardiol 107:271–280. https://doi.org/10.1007/s00392-018-1202-xCrossRefPubMedPubMedCentral

189.

Tonry C, Russell-Hallinan A, McCune C, Collier P, Harbinson M, Dixon L, Watson CJ (2023) Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction. Cardiovasc Res 119:710–728. https://doi.org/10.1093/cvr/cvac087CrossRefPubMed

190.

Totzeck M, Aide N, Bauersachs J, Bucerius J, Georgoulias P, Herrmann K, Hyafil F, Kunikowska J, Lubberink M, Nappi C, Rassaf T, Saraste A, Sciagra R, Slart R, Verberne H, Rischpler C (2023) Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging 50:792–812. https://doi.org/10.1007/s00259-022-05991-7CrossRefPubMed

191.

Totzeck M, Anker MS, Rassaf T (2023) CAR T-cell cancer therapies: do not forget the heart. Eur Heart J 44:2043–2045. https://doi.org/10.1093/eurheartj/ehad175CrossRefPubMed

192.

Totzeck M, Michel L, Lin Y, Herrmann J, Rassaf T (2022) Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies. Eur Heart J 43:1928–1940. https://doi.org/10.1093/eurheartj/ehac106CrossRefPubMedPubMedCentral

193.

Totzeck M, Mincu RI, Heusch G, Rassaf T (2019) Heart failure from cancer therapy: can we prevent it? ESC Heart Fail 6:856–862. https://doi.org/10.1002/ehf2.12493CrossRefPubMedPubMedCentral

194.

Totzeck M, Mincu RI, Mrotzek S, Schadendorf D, Rassaf T (2018) Cardiovascular diseases in patients receiving small molecules with anti-vascular endothelial growth factor activity: a meta-analysis of approximately 29,000 cancer patients. Eur J Prev Cardiol 25:482–494. https://doi.org/10.1177/2047487318755193CrossRefPubMed

195.

Totzeck M, Mincu RI, Rassaf T (2017) Cardiovascular adverse events in patients with cancer treated with bevacizumab: a meta-analysis of more than 20,000 patients. J Am Heart Assoc. https://doi.org/10.1161/jaha.117.006278CrossRefPubMedPubMedCentral

196.

Totzeck M, Schuler M, Stuschke M, Heusch G, Rassaf T (2019) Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol 280:163–175. https://doi.org/10.1016/j.ijcard.2019.01.038CrossRefPubMed

197.

Triguero-Cánovas D, López-Rodríguez-Arias F, Gómez-Martínez M, Sánchez-Guillén L, Peris-Castelló F, Alcaide-Quirós MJ, Morillas-Blasco P, Arroyo A, Ramírez JM (2023) Home-based prehabilitation improves physical conditions measured by ergospirometry and 6MWT in colorectal cancer patients: a randomized controlled pilot study. Support Care Cancer 31:673. https://doi.org/10.1007/s00520-023-08140-4CrossRefPubMed

198.

Tu H, Wen CP, Tsai SP, Chow WH, Wen C, Ye Y, Zhao H, Tsai MK, Huang M, Dinney CP, Tsao CK, Wu X (2018) Cancer risk associated with chronic diseases and disease markers: prospective cohort study. BMJ 360:k134. https://doi.org/10.1136/bmj.k134CrossRefPubMedPubMedCentral

199.

Vainshtein A, Tryon LD, Pauly M, Hood DA (2015) Role of PGC-1α during acute exercise-induced autophagy and mitophagy in skeletal muscle. Am J Physiol Cell Physiol 308:C710-719. https://doi.org/10.1152/ajpcell.00380.2014CrossRefPubMedPubMedCentral

200.

van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JA, Sonke GS, Aaronson NK (2015) Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol 33:1918–1927. https://doi.org/10.1200/jco.2014.59.1081CrossRefPubMed

201.

Waissengein B, Abu Ata B, Merimsky O, Shamai S, Wolf I, Arnold JH, Bar-On T, Banai S, Khoury S, Laufer-Perl M (2023) The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors. Clin Res Cardiol 112:409–418. https://doi.org/10.1007/s00392-022-02118-8CrossRefPubMed

202.

Wallen MP, Hennessy D, Brown S, Evans L, Rawstorn JC, Wong Shee A, Hall A (2020) High-intensity interval training improves cardiorespiratory fitness in cancer patients and survivors: a meta-analysis. Eur J Cancer Care (Engl) 29:e13267. https://doi.org/10.1111/ecc.13267CrossRefPubMed

203.

Waring CD, Vicinanza C, Papalamprou A, Smith AJ, Purushothaman S, Goldspink DF, Nadal-Ginard B, Torella D, Ellison GM (2014) The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. Eur Heart J 35:2722–2731. https://doi.org/10.1093/eurheartj/ehs338CrossRefPubMed

204.

Wernhart S, Balcer B, Rassaf T, Luedike P (2023) Increased dead space ventilation as a contributing factor to persistent exercise limitation in patients with a left ventricular assist device. J Clin Med. https://doi.org/10.3390/jcm12113658CrossRefPubMedPubMedCentral

205.

Wernhart S, Goertz A, Hedderich J, Papathanasiou M, Hoffmann J, Rassaf T, Luedike P (2023) Diastolic exercise stress testing in heart failure with preserved ejection fraction: The DEST-HF study. Eur J Heart Fail 25:1768–1780. https://doi.org/10.1002/ejhf.2995CrossRefPubMed

206.

Wernhart S, Hedderich J, Wunderlich S, Schauerte K, Weihe E, Dellweg D, Siemon K (2021) The feasibility of high-intensity interval training in patients with intensive care unit-acquired weakness syndrome following long-term invasive ventilation. Sports Med Open 7:11. https://doi.org/10.1186/s40798-021-00299-6CrossRefPubMedPubMedCentral

207.

Wernhart S, Mincu R, Balcer B, Rammos C, Muentjes C, Rassaf T (2023) The cardiorespiratory optimal point as a discriminator of lesion severity in adults with congenital heart disease. J Sports Med Phys Fitness 63:941–948. https://doi.org/10.23736/s0022-4707.23.14835-3CrossRefPubMed

208.

Wernhart S, Oster M, Schulze M, Papathanasiou M, Ruhparwar A, Rassaf T, Luedike P (2023) Moderate continuous and modified high-intensity interval training in patients with left ventricular assist devices: the prospective train-the-LVAD trial. J Card Fail 29:841–848. https://doi.org/10.1016/j.cardfail.2023.01.007CrossRefPubMed

209.

Wernhart S, Papathanasiou M, Jakstaite A, Hoffmann J, Schmack B, Hedderich J, Ruhparwar A, Rassaf T, Luedike P (2023) Exercise oscillatory ventilation in patients with advanced heart failure with and without left ventricular assist device. Artif Organs 47:168–179. https://doi.org/10.1111/aor.14398CrossRefPubMed

210.

Wernhart S, Papathanasiou M, Mahabadi AA, Rassaf T, Luedike P (2023) Betablockers reduce oxygen pulse increase and performance in heart failure patients with preserved ejection fraction. Int J Cardiol 370:309–318. https://doi.org/10.1016/j.ijcard.2022.10.009CrossRefPubMed

211.

Wernhart S, Papathanasiou M, Rassaf T, Luedike P (2023) The controversial role of beta-blockers in heart failure with preserved ejection fraction. Pharmacol Ther 243:108356. https://doi.org/10.1016/j.pharmthera.2023.108356CrossRefPubMed

212.

Wernhart S, Papathanasiou M, Rassaf T, Luedike P (2023) Heart failure classification based on resting ejection fraction does not display a unique exercise response pattern. Int J Cardiol 376:157–164. https://doi.org/10.1016/j.ijcard.2023.01.072CrossRefPubMed

213.

West MA, Lythgoe D, Barben CP, Noble L, Kemp GJ, Jack S, Grocott MP (2014) Cardiopulmonary exercise variables are associated with postoperative morbidity after major colonic surgery: a prospective blinded observational study. Br J Anaesth 112:665–671. https://doi.org/10.1093/bja/aet408CrossRefPubMed

214.

West MA, Parry MG, Lythgoe D, Barben CP, Kemp GJ, Grocott MP, Jack S (2014) Cardiopulmonary exercise testing for the prediction of morbidity risk after rectal cancer surgery. Br J Surg 101:1166–1172. https://doi.org/10.1002/bjs.9551CrossRefPubMed

215.

White E, Mehnert JM, Chan CS (2015) Autophagy, metabolism, and cancer. Clin Cancer Res 21:5037–5046. https://doi.org/10.1158/1078-0432.Ccr-15-0490CrossRefPubMedPubMedCentral

216.

WHO (2022) Cancer Key Facts. In:

217.

Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO (2000) Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88:2219–2226. https://doi.org/10.1152/jappl.2000.88.6.2219CrossRefPubMed

218.

Wisløff U, Støylen A, Loennechen JP, Bruvold M, Rognmo Ø, Haram PM, Tjønna AE, Helgerud J, Slørdahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen Ø, Skjaerpe T (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115:3086–3094. https://doi.org/10.1161/circulationaha.106.675041CrossRefPubMed

219.

Wonisch M, Hofmann P, Fruhwald FM, Kraxner W, Hödl R, Pokan R, Klein W (2003) Influence of beta-blocker use on percentage of target heart rate exercise prescription. Eur J Cardiovasc Prev Rehabil 10:296–301. https://doi.org/10.1097/00149831-200308000-00013CrossRefPubMed

220.

Yang L, Morielli AR, Heer E, Kirkham AA, Cheung WY, Usmani N, Friedenreich CM, Courneya KS (2021) Effects of exercise on cancer treatment efficacy: a systematic review of preclinical and clinical studies. Cancer Res 81:4889–4895. https://doi.org/10.1158/0008-5472.Can-21-1258CrossRefPubMedPubMedCentral

221.

You Y, Lai X, Pan Y, Zheng H, Vera J, Liu S, Deng S, Zhang L (2022) Artificial intelligence in cancer target identification and drug discovery. Signal Transduct Target Ther 7:156. https://doi.org/10.1038/s41392-022-00994-0CrossRefPubMedPubMedCentral

222.

Yun J, Mullarky E, Lu C, Bosch KN, Kavalier A, Rivera K, Roper J, Chio II, Giannopoulou EG, Rago C, Muley A, Asara JM, Paik J, Elemento O, Chen Z, Pappin DJ, Dow LE, Papadopoulos N, Gross SS, Cantley LC (2015) Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. Science 350:1391–1396. https://doi.org/10.1126/science.aaa5004ADSCrossRefPubMedPubMedCentral

223.

Zong WX, Rabinowitz JD, White E (2016) Mitochondria and cancer. Mol Cell 61:667–676. https://doi.org/10.1016/j.molcel.2016.02.011CrossRefPubMedPubMedCentral

224.

Zucker IH, Musch TI (2018) Benefits of exercise training on cardiovascular dysfunction: molecular and integrative. Am J Physiol Heart Circ Physiol 315:H1027-h1031. https://doi.org/10.1152/ajpheart.00516.2018CrossRefPubMed

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Exercise, cancer, and the cardiovascular system: clinical effects and mechanistic insights

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content